What is the recommended dosage and usage of finasteride (1mg oral) for treating male pattern baldness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Finasteride 1mg Oral for Male Pattern Hair Loss

Recommended Dosage

Take finasteride 1mg once daily for male pattern hair loss, with treatment continuing long-term (5+ years) to maintain benefits, as hair loss resumes upon discontinuation. 1, 2

Treatment Protocol

Dosing Specifics

  • Standard dose: 1mg once daily for men aged 18-60 years with male pattern hair loss 1, 2
  • The 1mg dose produces similar DHT suppression (approximately 50%) as the 5mg dose used for benign prostatic hyperplasia 3, 2
  • No dose adjustment needed based on age within the approved range 1

Timeline for Results

  • Visible improvement typically begins by 12 weeks of treatment 1
  • Maximal benefit occurs at 1-2 years of continuous use 1
  • Efficacy is maintained over 5+ years with continued treatment 1, 4
  • In long-term studies, 58% of men showed improvement at 48 weeks, and 66% showed improvement at 2 years 5, 6

Duration of Treatment

  • Plan for lifelong treatment if you want to maintain hair growth benefits 1
  • Hair loss resumes if treatment is discontinued 1
  • Treatment continuation beyond 5 years can provide additional improvements in 21% of cases 7

Important Clinical Considerations

PSA Monitoring (Critical Pitfall)

  • Finasteride 1mg reduces PSA levels by approximately 50% after 12 months, identical to the 5mg dose 3, 2
  • Double the PSA value when screening for prostate cancer in men taking finasteride after 12 months of therapy 3, 2
  • Consider obtaining baseline PSA before starting treatment in men approaching prostate cancer screening age (>40-45 years) 1

Sexual Side Effects

  • Sexual dysfunction occurs in approximately 2-4% more patients taking finasteride compared to placebo 1, 8
  • Specific effects include decreased libido, ejaculation disorders, and erectile dysfunction 1, 6
  • The magnitude is relatively small: mean difference of 3.21 points on sexual function scales versus 1.26 points for each year of aging 1, 8
  • All sexual adverse events reverse upon discontinuation, and many resolve even with continued therapy 6, 9
  • Overall discontinuation rates due to adverse events are similar between finasteride (6-7%) and placebo groups 8

Fertility Considerations

  • Evidence regarding direct fertility impact is inconclusive for the 1mg dose 1, 8
  • Sexual side effects may indirectly affect fertility by impacting sexual function 8
  • The 5mg dose is associated with reduced semen volume, but data for 1mg is less clear 8

Patient Counseling Points

Setting Realistic Expectations

  • Counsel patients that improvement takes 12 weeks minimum to become visible 1
  • Explain that maximal benefit requires 1-2 years of treatment 1
  • Better results are observed in patients older than 30 years; 42.8% of men aged 20-30 years showed no improvement even after 10 years 7
  • Patients with higher AGA grades (IV-V) may take longer to show initial improvement 7

Safety Profile

  • Finasteride is generally well tolerated with no new safety concerns identified during long-term use up to 10 years 4, 7
  • Treatment-related adverse events occur in 7.7% of finasteride recipients versus 7.0% of placebo recipients 6
  • Most adverse events are mild to moderate in severity 6

Contraindications

  • Absolutely contraindicated in pregnant women due to risk of hypospadias in male fetuses 6
  • Women of childbearing potential should not handle crushed or broken tablets 6

References

Guideline

Finasteride for Male Pattern Hair Loss: Efficacy and Safety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Finasteride Dosing and Clinical Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Finasteride in the treatment of Japanese men with male pattern hair loss.

European journal of dermatology : EJD, 2004

Guideline

Finasteride 1mg and Male Fertility

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Guidelines on the use of finasteride in androgenetic alopecia.

Indian journal of dermatology, venereology and leprology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.